← All trials
NCT04381468
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2020
- Primary completion
- Nov 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- May 8, 2020
- Last posted
- May 8, 2020
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vaccinex Inc.Lead sponsor
- Vaccinex Inc.Study director
- Alzheimer's AssociationCollaborator
- Alzheimer’s Drug Discovery FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.